Skip to main content
. Author manuscript; available in PMC: 2018 Mar 1.
Published in final edited form as: FEBS Lett. 2017 Feb 17;591(5):801–809. doi: 10.1002/1873-3468.12571

Figure 2. Muscle cross-sectional area and capillary density.

Figure 2

Changes in (A) muscle cross-sectional area and (B) capillary density in control or PDGFR inhibitor treated mice. (C–F) representative immunohistochemistry for extracellular matrix and capillaries is shown. Values are mean±SD. N=8 per group. Dashed line indicates data from non-overloaded mice. Differences tested with a two-way ANOVA followed by Holm-Sidak post-hoc sorting. a, significantly different (P<0.05) from 3D control; b, significantly different (P<0.05) from 3D PDGFR inhibitor; c, significantly different (P<0.05) from 10D control.